Description:

Nebusal is a hypertonic saline solution used to help produce sputum (mucus or phlegm) to improve lung function in individuals with respiratory conditions like cystic fibrosis.

Prescription:

• Available by prescription.

Dosage:

• Administered via nebulization using a nebulizer device.
• The specific concentration and frequency should be determined by a healthcare professional based on individual needs.

Therapeutic Category:

• Mucolytic Agent.

Active Ingredients/Composition:

• Sodium Chloride (NaCl) in concentrations of 3%, 6%, or 7% per 4 mL unit-dose vial.

Variant:

• Available in different concentrations: 3%, 6%, and 7% sodium chloride solutions.

Consume Type:

• Inhalation via nebulizer.

Directions/Usage:

• Use as directed by a healthcare professional.
• Twist and pull off the top of the vial, invert, and squeeze the prescribed volume into the nebulizer cup.
• Inhale the mist produced by the nebulizer through the mouth.

Common Side Effects:

• Possible side effects include coughing, throat irritation, or a salty taste.
• Seek medical attention if you experience signs of an allergic reaction, such as rash, itching, swelling, severe dizziness, or trouble breathing.

Package Type:

• Single-use plastic vials containing 4 mL solution, typically packaged in cartons of 60 vials.

Storage Advice:

• Store at room temperature between 15°C to 30°C (59°F to 86°F).
• Avoid excessive heat and protect from freezing.

Safety Advice:

• Uatory issues or are taking other medications.

Product Substitutes:

• Other hypertonic saline solutions for inhalation, such as HyperSal or PulmoSal.

Manufacturer/Marketer:

• Man Asept Pak, Inc., Malone, NY 12953.

Country of Origin:

• United States.